Roundtables

Small, participant-led discussions where the HealthXL community discuss digital health challenges and offer solutions.

19th March 2024 @ 12pm ET

Emerging Trends: Decentralised to Home-based Clinical Trials

The landscape of cancer care is evolving, with startups changing the field by bringing care to patients' homes.

Hansa Bhargava
Featuring
Hansa Bhargava
Chief Clinical Strategy and Innovation Officer, Healio
20th March 2024 @ 12pm ET

Exploring Gen AI in the Pharmaceutical Industry

Gen AI in pharma is an emerging field that leverages AI to enhance various aspects of the pharmaceutical industry.

Dave Peak
Featuring
Dave Peak
Advisor, Independent
21st March 2024 @ 12pm ET

Unlocking AI's Potential in Medical Affairs

AI has significant potential to unlock new opportunities in medical affairs within the pharma industry.

Robert Stevens
Featuring
Robert Stevens
Principal, RS CONSULTATIVE, LLC
26th March 2024 @ 12pm ET

Managing Risks and Maximising ROI Strategies

Managing risks and maximising ROI is the new mantra of digital health investors.

Adam Kaufman
Featuring
Adam Kaufman
Senior Advisor, EVERSANA
2nd April 2024 @ 11am ET

Where is Gen AI generating ROI?

The buzz surrounding AI's role in healthcare is undeniable.
Featuring
04TH APRIL 2024 @ 11AM ET

Patient & Site Engagement: How Can Technology Improve Trial Experiences

In the dynamic landscape of clinical trials, technology stands as a transformative force, reshaping patient and site engagement for the better.

Meri Beckwith
Featuring
Meri Beckwith
Co-Founder at Lindus Health
9th April 2024 @ 11am ET

How Digital Diagnostics Enable Precision Medicine

The acceleration of advanced analytics, propelled by artificial intelligence and Big Data, is expanding possibilities to unlock the power of collected data.

Dr Kamala Maddali
Featuring
Dr Kamala Maddali
President and Founder, Health Collaborations LLC
11th April 2024 @ 11am ET

PDT 2.0: The Future of Prescription Digital Therapeutics

Prescription digital therapeutics were the centre of all attention in the past years with millions of funding dollars flowing in with the promise of a bright future.
Mike Pace
Featuring
Mike Pace
CEO & Founder, PalmHealth.co
16TH APRIL 2024 @ 11AM ET

Big Tech and Pharma: Will they, won't they?

As Big Tech seeks to expand their footprint in the health industry, the dynamics of their relationship with Pharma are under scrutiny.

Featuring
18th April 2024 @ 11am ET

BYOD: What's your Wearable of Choice?

Wearables, like smartwatches and fitness trackers, have transformed patient health monitoring, providing real-time data for personalised care.

Ralph Morales III
Featuring
Ralph Morales III
Director, Healthcare Innovation, Oura
30TH APRIL 2024 @ 11AM ET

Tech-Enabled Health in Cardiovascular Disease

The integration of technology in cardiovascular disease (CVD) management holds significant potential for pharma and healthcare alike.

Manuel Roemer
Featuring
Manuel Roemer
Chief Strategy & Business Development, Exploris Health AG
2nd May 2024 @ 11am ET

Redesigning Patient Experiences: Infusion Therapies

In the ever-evolving landscape of healthcare, the focus on patient-centricity has become increasingly paramount.
Featuring
7th May 2024 @ 11am ET

Game Changer? DTx on Drug Labels

The digital therapeutics market has experienced fluctuations, but a potential turning point has emerged with the release of new FDA guidance.
Featuring
9th May 2024 @ 11am ET

Digital Pain Management: Does it Work?

In today's healthcare landscape, effective pain management is a cornerstone of patient care, with millions worldwide seeking relief from acute and chronic pain.
Featuring
14th May 2024 @ 11am ET

Lessons in Therapy: What Diabetes Can Teach Other Chronic Diseases

As digital health continues its transformative journey, the experiences gained in diabetes management can serve as a guiding light for broader applications
Featuring
15th May 2024 @ 11am ET

Multi-Condition SaMD: Regulatory Requirements and Future Implications

Obtaining SaMD approval is no easy task, as it requires rigorous evidence generation and efficacy demonstration to ensure patient safety and usability.
Featuring
21st May 2024 @ 11am ET

Designing Personalised Patient Experience for Pharma Brands

In the current landscape, designing personalised patient experiences for pharma brands is both a challenge and an opportunity.

Featuring
28th May 2024 @ 11am ET

Health is Wealth in Hindsight: Leveraging Digital Health for Prevention

Digital health is emerging as a powerful ally in the realm of preventive healthcare, reshaping the landscape by offering innovative solutions and transformative strategies.

Kate O'Reilly
Featuring
Kate O'Reilly
Manager, Health & Life Sciences, EY
29th May 2024 @ 11am ET

What Does Innovation Look Like in Neurodegenerative Diseases?

Digital health technologies hold potential to revolutionise the patient journey in neurodegenerative disease, from early detection to ongoing management and support.

Kate O'Reilly
Featuring
Kate O'Reilly
Manager, Health & Life Sciences, EY
4th June 2024 @ 11am ET

Quantifying the Benefits of Digital Biomarkers in Pharma

The pharmaceutical industry faces a constant challenge: demonstrating the true value of innovative solutions.

Featuring
6th June 2024 @ 11am ET

It's Getting Hot in Here! Innovation for Menopause

Innovation in menopause, coupled with advancements in digital health, is revolutionising the landscape of women's health and wellness during this life stage.

Featuring
11th June 2024 @ 11am ET

Innovation in Senior Care

From advanced healthcare technologies to novel care delivery models, the landscape of senior care is evolving to meet the diverse and evolving needs of ageing individuals.

Kate O'Reilly
Featuring
Kate O'Reilly
Manager, Health & Life Sciences, EY
12th June 2024 @ 11am ET

DTx: A Comeback?

Digital therapeutics (DTx) has been a rapidly growing sector in healthcare, attracting significant investment.
Featuring
13th June 2024 @ 11am ET

Inflammatory Conditions: Trigger 360 Degree Care

Inflammatory conditions, encompassing a myriad of diseases from arthritis to inflammatory bowel diseases, pose significant challenges to both patients and healthcare providers worldwide. T

Featuring
25th June 2024 @ 11AM ET

GenAI Doctors: Can they be Trusted?

The algorithms powering GenAI Doctors are only as reliable as the data they are trained on, and biases within that data may inadvertently impact their recommendations.

Featuring
9th July 2024 @ 11am ET

Do Accelerators Work to Nurture Innovation?

Accelerators play a crucial role in nurturing innovation in pharma by bringing together diverse and innovative stakeholders to create a collaborative ecosystem that fosters the exchange of ideas, expertise, and best practices most conducive to breakthrough discoveries and advancements.
Featuring
10th July 2024 @ 11am ET

How to Scale Partnerships Between Lifesciences and Digital Health Companies?

Pharma companies have identified technology as an opportunity to deliver more value to their patients and clinicians and differentiate from other competitors.
Featuring
11th July 2024 @ 11am ET

The Evolving Landscape of Digital Measures in Pharma

The evolving landscape of digital measures in pharma is a complex and dynamic field with emerging challenges and opportunities.
Featuring
30th July 2024 @ 11am ET

Customer Experience is a New Role in Pharma - What Does it Really Mean?

The pharma industry is increasingly shifting towards prioritising the needs and satisfaction of patients and healthcare providers, oftentimes through technology.
Featuring
1st August 2024 @ 11am ET

Digital Biomarkers in Neurology: Early Diagnosis and Disease Management

Neurological disorders, given their intricate nature and often elusive markers, pose a significant challenge to neurologists striving for early diagnosis and effective treatment.
Featuring
3rd September 2024 @ 11am ET

Why the Employer Pathway is not your Business Model

Large, self-insured employers are the main buyers of digital health solutions for employee benefits.
Featuring
12th March 2024 @ 12pm ET

Commercialisation Models for PDT's

Commercialisation models for PDTs are still evolving. It’s not always a straightforward process of checking a box for approval or determining whether a PDT should be over-the-counter or prescription-based.

Hannes Klöpper
Featuring
Hannes Klöpper
CEO, HelloBetter
7th March 2024 @ 11am ET

Repositioning the Role of DTx in the Industry

Repositioning the role of DTx is a complex and multifaceted task that requires addressing challenges related to reimbursement, alignment with public health priorities, clarity on pathways to market, and provider engagement.

Mike Pace
Featuring
Mike Pace
CEO & Founder, PalmHealth.co
5th March 2024 @ 11am ET

Tech Enabled Change in Oncology Workflows

The demand for oncology services is increasing, while the supply for oncologists is decreasing. This creates immense pressure to meet the growing demand for cancer care.

Lynda Chin
Featuring
Lynda Chin
Founder, President and CEO, Apricity Health
20th February 2024 @ 11am ET

Navigating Diverse Markets for Digital Health Success

Success in diverse digital health markets requires more than just understanding the unique challenges and opportunities they present.


Craig Cooper
Featuring
Craig Cooper
Investment Director, Diabetes Venture Fund, Serpentine Ventures
15th February 2024 @ 11am ET

The Future of Companion Diagnostics - Digital Biomarkers

The integration of digital technologies into healthcare has opened up new avenues for personalised medicine and patient-centred care.

Ciara Clancy
Featuring
Ciara Clancy
Founder & CEO, Beats Medical Ltd
13th February 2024 @ 11am EDT

Real World Data in Clinical Trials: Benefits and Best Practices

The utilisation of RWD provides numerous benefits, including improved external validity, broader patient representation, longitudinal data analysis, and improved post-market surveillance.

Joris van Dam
Featuring
Joris van Dam
VP Data Innovation, Exact Sciences
8th February 2024 @ 11am ET

Customer Experience is a New Role in Pharma - What Does it Really Mean?

The pharma industry is increasingly shifting towards prioritising the needs and satisfaction of patients and healthcare providers, oftentimes through technology.

Ciara Clancy
Featuring
Ciara Clancy
Founder & CEO, Beats Medical Ltd
6th February 2024 @ 11am ET

Obesity Management: Convergence Of Market Shaping Drugs And Virtual Care

The combination of market-shaping drugs and virtual care offers a promising solution to the complex and widespread problem of obesity.


Lauren Bataille
Featuring
Lauren Bataille
Head of Digital Patient Health & Innovation - Cardiovascular, Renal & Metabolism at AstraZeneca
1st February 2024 @ 11am ET

Pharmacy as a Catalyst to Scale Digital Health

As digital health continues to revolutionise the healthcare industry, pharmacies are poised to play a crucial role in scaling these innovative technologies.


Mike Pace
Featuring
Mike Pace
CEO & Founder, PalmHealth.co
25th January 2024 @ 11am ET

The Microbiome: The Gut-Mental-Digital Connection

The fascinating area of research surrounding the human microbiome includes exploring the intriguing connection between the gut microbiome and mental health.


Ravi Janapureddy
Featuring
Ravi Janapureddy
Co-founder & CEO at RCube Health
Digital Health Meeting
24th January @ 11:00am ET

Scientific Exchange

While the potential of digital health in Oncology remains untapped, advancements indicate promising avenues for integrating digital tools in cancer care.
Featuring
24th January 2024 @ 11am ET

From Approval to Access and Adoption: Leveraging Real-World Data for Medical Devices

Collection of data in the real world is ubiquitous. Some of the medical device vendors fully utilize this trend while others are in the early stages of exploring how different data sources can support different use cases throughout the medical devices lifecycle.

Piotr Sokolowski
Featuring
Piotr Sokolowski
Head of Strategy, MedTech Solutions at S3 Connected Health
Digital Therapeutics (DTx)
18th January @ 11:00am ET

Do Accelerators Work to Nurture Innovation?

Accelerators play a crucial role in nurturing innovation in pharma by bringing together diverse and innovative stakeholders to create a collaborative ecosystem that fosters the exchange of ideas, expertise, and best practices most conducive to breakthrough discoveries and advancements.

Sophie Park
Featuring
Sophie Park
Managing Director, Bayer G4A Digital Health
17th January 2024 @ 11am EDT

The Complete Story: Using RWE to Better Understand the Patient Experience

The use of real-world evidence (RWE) in pharmaceutical R&D has increased significantly in recent years.
Brett Wisse
Featuring
Brett Wisse
Director Commercial Operations, Pack Health
Digital Health Meeting
16th January @ 11:00am ET

The Role of AI Across the Clinical Trial Landscape

Clinical trials face hurdles in patient selection, recruitment, and retention, causing delays and insufficient participation.

Craig Lipset
Featuring
Craig Lipset
Advisor & Founder, Clinical Innovations Partners
Digital Health Meeting
4th January @ 11:00am ET

How to Scale Partnerships Between Lifesciences and Digital Health Companies?

Pharma companies have identified technology as an opportunity to deliver more value to their patients and clinicians and differentiate from other competitors.

Piotr Sokolowski
Featuring
Piotr Sokolowski
Head of Strategy, MedTech Solutions at S3 Connected Health
Digital Health Meeting
5th December @ 11:00am ET

Revolutionising Pharma: AI's Impact on the Value Chain

The pharma sector is harnessing the power of AI across various key areas. 


Jeremy Forman
Featuring
Jeremy Forman
Executive Director Data Strategy, Data Science, & Data Platforms at Seagen
30th November @ 11:00am ET

Should AI Have a Role in Mental Health Therapy?

Exploring the role of AI in mental health therapy can revolutionise access, affordability, and effectiveness of treatment for countless individuals.  

Mimi Winsberg, M.D.
Featuring
Mimi Winsberg, M.D.
Chief Medical Officer and Co-Founder, Brightside Health
Digital Health Meeting
28th November @ 11:00am ET

Scaling Success & Profitability in Digital Health

Scaling up a digital health business requires careful planning and execution.

Brett Wisse
Featuring
Brett Wisse
Director Commercial Operations, Pack Health
Digital Health Meeting
21st November @ 11:00am ET

DTx: A Comeback?

Digital therapeutics (DTx) has been a rapidly growing sector in healthcare, attracting significant investment. However, recent challenges, including market conditions and financing difficulties, have cast a shadow over the industry. 


Dani Bradley
Featuring
Dani Bradley
Senior Director of Clinical Value & Evidence, Big Health
Digital Health Meeting
14th November @ 11:00am ET

Navigating AI Regulation in Healthcare

The regulatory landscape for AI in healthcare can be quite unclear and challenging to navigate for manufacturers and developers. 

Bernhard Kappe
Featuring
Bernhard Kappe
Founder & CEO, Orthogonal
Digital Therapeutics (DTx)
13th November @ 11:00am ET

PDT 2.0: The Future of Prescription Digital Therapeutics

Prescription digital therapeutics were the centre of all attention in the past years with millions of funding dollars flowing in with the promise of a bright future.  


David Klein
Featuring
David Klein
Co-Founder & CEO, Click Therapeutics
Digital Health Meeting
9th November @ 11:00am ET

Advancing Digital Oncology: the Provider Perspective

For providers, it is crucial to prioritise opportunities for innovation in oncology and consider equity and inclusion when developing digital solutions.  While digital innovation is not a cure-all for cancer, it can greatly impact patient care if we embrace solutions that have been designed for the complexities of the disease.

Andrew Norden
Featuring
Andrew Norden
Chief Medical Officer, OncoHealth
Clinician and Patient Engagement & Support
7th November @ 11:00am EDT

The Science of Digital Patient Engagement

Digital patient engagement is a multidisciplinary field that combines various fields and research. It encompasses neurological requirements for behavioural change, guiding principles for sustained engagement, mechanisms for behavioural economic activation, principles of digital game design, and stages of behaviour change.


Chris Wasden
Featuring
Chris Wasden
Chief Strategy Officer, Twill
Digital Health Meeting
2nd November @ 11:00am EDT

Pharma and Telehealth: Evolving Parameters of Engagement

Pharma and telehealth hold the key to a future where healthcare is accessible, efficient, and patient-centred.


Aahuti Rai
Featuring
Aahuti Rai
Strategic Advisor, Healthcare Innovation at Four Points Consulting Ltd
Digital Health Meeting
27th October @ 11:00am EDT

Does AI Guarantee ROI?

The buzz surrounding AI's role in healthcare is undeniable. Yet, amidst these discussions, a key question remains: Where should AI be harnessed to truly optimize return-on-investment (ROI)?


Dr Keith Tsui
Featuring
Dr Keith Tsui
CEO & Co-Founder, Medwise.ai
Digital Health Meeting
26th October @ 11:00am EDT

Designing Personalised Patient Experience for Pharma Brands

In the current landscape, designing personalised patient experiences for pharma brands is both a challenge and an opportunity.

Christof Wedemeyer
Featuring
Christof Wedemeyer
Director, Patient Experience Design & Solutions | TA Cardiovascular, Norvartis
Digital Health Meeting
24th October @ 11:00am EDT

PDT 2.0: The Future of Prescription Digital Therapeutics

The future of prescription digital therapeutics holds immense potential in revolutionising healthcare delivery and improving health outcomes.

David Klein
Featuring
David Klein
Co-Founder & CEO, Click Therapeutics
Digital Health Meeting
11th October @ 11:00am EDT

Evaluating Health Economic Outcomes of DTx

2023 has been a challenging year for DTx, and now, more than ever, it has become increasingly important for DTx solutions to showcase robust health economics to secure stakeholder buy-in.



Rick Bartels
Featuring
Rick Bartels
Managing Partner , DTxCC
Digital Health Meeting
4th October @ 11:00am

Enhancing Patient Experiences with Data-Driven Insights

In the modern healthcare landscape, the importance of leveraging data-driven insights to enhance patient experiences cannot be overstated. Pharmaceutical companies need to connect with patients because it can bring about big changes in how healthcare is provided

Dr. Maximilian Hahn
Featuring
Dr. Maximilian Hahn
Cx Excellence Director at Daiichi Sankyo
Digital Health Meeting
21st September @ 11:00am EDT

Pharma's Role in Remote Patient Monitoring in Oncology

Remote patient monitoring (RPM) is a key component of digital health, especially in the field of oncology.

Gandolf Finke
Featuring
Gandolf Finke
Founder & MD at Mika / Fosanis
Digital Health Meeting
20th September @ 11:00am EDT

MedTech: New Revenue Opportunities with Digital, Data and Connectivity

Are you struggling to establish digital as a cornerstone of your revenue generation strategy? Then this session is for you!

Piotr Sokolowski
Featuring
Piotr Sokolowski
Head of Strategy, MedTech Solutions at S3 Connected Health
Digital Health Meeting
13th September @ 11:00AM EDT

Business Models for Virtual Care Delivery

In a market progressively gravitating toward decentralised, consumer-centric healthcare delivery, the business models we use for virtual care must adapt and grow too. Different approaches are constantly emerging, and there’s no one-size-fits-all solution. 

Rebecca Gwilt
Featuring
Rebecca Gwilt
Partner, Nixon Gwilt Law
Digital Mental Health & Neurology
12th September 2023 @ 11:00 AM EDT

Digital Biomarkers in Neurology: Early Diagnosis & Disease Management

Neurological disorders, given their intricate nature and often elusive markers, pose a significant challenge to neurologists striving for early diagnosis and effective treatment.

Brian Nahed
Featuring
Brian Nahed
Neurosurgeon and Program Director, Massachusetts General Hospital
Digital Health Meeting
11th September @ 11:00am EDT

Sustainable Business Models for Remote Patient Monitoring Solutions

What are the best routes to market for Remote Patient Monitoring (RPM) companies? A survey from 2020 suggested that 55 to 58% of European physicians believe that Remote Patient Monitoring (RPM) will play a key role in the future of care.
Johannes Munding
Featuring
Johannes Munding
Associate Director Digital Health Solutions at Novartis
Digital Therapeutics (DTx)
6th September 2023 @ 11:00 AM EDT

Pharma 3.0: A framework for doing digital health better

Digital health’s interaction with pharma is evolving; it has to evolve. Join this expert led discussion where we will deep dive into the future of Pharma. Seats are limited so apply now to secure your place.

Frank Chavez
Featuring
Frank Chavez
Head of Strategy & Transformation, Otsuka Precision Health
Digital Health Meeting
6th September @ 11:00am EDT

Upskilling Medical Affairs for Digital Health

In an era of digital transformation, the way in which we care and treat patients is fundamentally being altered.

Reinhard Berkels
Featuring
Reinhard Berkels
Head of Medical Affairs Strategy, IQVIA
Digital Therapeutics (DTx)
31st August 2023 @ 11:00 AM EDT

Evidence Generation: What payers are looking for

Establishing the effectiveness of your solutions and securing reimbursement can be a daunting task. In the evolving reimbursement landscape, presenting a compelling value proposition and robust evidence base becomes crucial.

Leonardo Angelone
Featuring
Leonardo Angelone
Deputy Director, Office of Translational Initiatives and Program Innovations, The National Institutes on Drug Abuse
Digital Health Meeting
30th August 2023 @ 11:00 AM EDT

Designing Agile and Responsive Pharma Patient Experience to Improve Drug Adherence

As the landscape of pharmaceuticals evolves, understanding and adapting to emerging, tech-enabled patient journeys is critical. Improving these journeys is central to enriching patient experiences and, by extension, improving treatment adherence.



Sander Ruitenberg
Featuring
Sander Ruitenberg
Global Digital Health Solutions Head, Novartis
AI in Healthcare
29th August 2023 @ 11:00 AM EDT

Balancing AI and Human Involvement in Digital Health

As artificial intelligence gains traction in healthcare, the industry finds itself at a crossroads, torn between the anticipation of AI's vast potential and the concerns surrounding ethical and patient safety issues. Join HealthXL as we deep dive into this session, register now to secure your place.



Keith Grimes
Featuring
Keith Grimes
Primary Care Physician, Digital Health & Innovation Consultant, and Founder of Curistica
Digital Health Meeting
17th August 2023 @ 10:45AM EDT

Quantifying the Benefits of Digital Biomarkers in Pharma

This session is an invite-only meeting. To find out more please contact us.

With the rise of connected sensor technologies, and wearable devices that can offer objective, continuous patient measurements, healthcare stakeholders are presented with a wealth of opportunities to innovate how we measure health.

Efren Rael
Featuring
Efren Rael
Senior Medical Director, Clinical Affairs, Biofourmis
Digital Mental Health & Neurology
15th August 2023 @ 11:00 AM EDT

Mental Health: Getting your D2C Solution to be the Consumer's Top Pick

Compared to other therapeutic areas, mental health presents itself as an area ripe for sustainable direct-to-consumer (D2C) business models. Join us as we delve into these trends within the digital mental health landscape, and explore effective strategies when going down the D2C route.

Benjamin Alouf
Featuring
Benjamin Alouf
Member Scientific Advisory Board, Big Health
Digital Therapeutics (DTx)
10th August 2023 @ 11:00AM EDT

Are open source DTx solutions the path to scalability?

Since the inception of medicine, practitioners have been sharing observations and best practices.



Chris Cera
Featuring
Chris Cera
CEO, Arcweb Technologies
Telemedicine & Virtual Care Delivery
27th July 2023 @ 11:00 AM EDT

How Can Pharma Companies Get the Most Out of a Platform Approach?

With new platform technologies emerging, there is an opportunity to elevate pharma’s digital initiatives to a more flexible and globally compliant framework that can scale across multiple markets and therapy areas. Join your peers in this interactive discussion. Seats are limited so apply now to secure your place.

Nayan Kalnad
Featuring
Nayan Kalnad
CEO at Avegen
AI in Healthcare
26th July 2023 @ 11:00 AM EDT

From Algorithms to Assets: Monetising Real-World Patient Data with AI

Artificial Intelligence (AI) is disrupting traditional business models by extracting deeper insights from diverse data sets. Join HealthXL in this meeting to deep dive into this topic with your peers working in this space. Seats are limited so apply now to secure your place.

Lisa Suennen
Featuring
Lisa Suennen
Managing Partner, Venture Valkyrie, LLC
Telemedicine & Virtual Care Delivery
26th July 2023 @ 10:45 EST

Adherence in the U.S: Are We Making the Right Assessments and How Can Improvements Be Made?

The patient experience is becoming increasingly recognised as a major component of chronic condition treatment delivery. Join us in this roundtable discussion led by Health Beacon where we will deep dive into this topic. Spaces are limited so apply now to secure your seat.

Jim Joyce
Featuring
Jim Joyce
CEO, HealthBeacon
Digital Mental Health & Neurology
24th July 2023 @ 11:00 AM EDT

Adoption Of Digital Mental Health Solutions: How Cultural Differences Affect Uptake

Cultural context significantly influences perceptions and approaches to mental health conditions.

Renae Beaumont
Featuring
Renae Beaumont
Ph.D. Psychology, Weill Cornell Medicine
Digital Health in Oncology
20th July 2023 @ 10:45AM EDT

Advancing Digital Oncology Through Public-Private Partnerships

We have made remarkable progress in oncology treatments, yet, many patients are still grappling with basic, and often preventable, barriers to care.

Stephen Konya
Featuring
Stephen Konya
Senior Advisor to the Deputy National Coordinator for Health IT and Innovation Portfolio Lead at U.S. Department of Health and Human Services (HHS)
Telemedicine & Virtual Care Delivery
19th July @ 10:45AM EDT

Partnership Roadmap with Life Sciences Companies for Digital Health in Cardiometabolic Diseases

Life sciences companies and digital health startups are teaming up to improve outcomes and reduce the burden of cardiometabolic diseases. Join HealthXL in this session to deep dive into this topic. Apply now to secure your place.

Abhishek Shah
Featuring
Abhishek Shah
CEO, Wellthy Therapeutics
Telemedicine & Virtual Care Delivery
18th July @ 10:45AM EDT

Patients as Consumers: Why Pharma Must Deliver a Convenient, Connected Patient Experience

The consumerisation of healthcare has given rise to a new generation of patient with heightened expectations for seamless and personalised experiences.


Aquil Harjivan
Featuring
Aquil Harjivan
R&D Head – Digital Health, Bayer Consumer Health
Telemedicine & Virtual Care Delivery
13th July 2023 @ 10:45AM EDT

The New Role of Medical Affairs: Enabling Digital HCP Engagement and Scientific Communication

Digital health is changing the Medical Affairs (MA) function; the introduction of connected technology alongside drugs provides MA with new methods of reaching patients and their physicians.

Kevin Darcy
Featuring
Kevin Darcy
Director, Link Strategy at Veeva Systems
Digital Therapeutics (DTx)
29th June @ 10:45AM EDT

Pharma 3.0: Doing Digital Health Better

Digital health’s interaction with pharma is evolving; it has to evolve. Join us in this exclusive roundtable where we will discuss the highlights from our recent HealthXL Pharma 3.0 report and how pharma can do digital health better in the next few years.

Jeremy Sohn
Featuring
Jeremy Sohn
Managing General Partner, P74 Ventures
Telemedicine & Virtual Care Delivery
28th June 2023 @ 10:45AM EDT

Adherence in the U.S: Are We Making the Right Assessments and How Can Improvements Be Made?

The patient experience is becoming increasingly recognised as a major component of chronic condition treatment delivery. Join us in this roundtable discussion led by Health Beacon where we will deep dive into this topic. Spaces are limited so apply now to secure your seat.

Jim Joyce
Featuring
Jim Joyce
CEO, HealthBeacon
Digital Mental Health & Neurology
27th June 2023 @ 10:45AM EDT

Digital Assessments in Remote Trials: Exploring Pharma's Implementation Strategies

The integration of digital assessments, digital-enabled measures as well as novel digital biomarkers, into clinical trials has created a new era of patient-centric and decentralised trials. Apply now to join your peers in this discussion. Seats are limited so apply now to secure your place.

Ciara Clancy
Featuring
Ciara Clancy
Founder & CEO, Beats Medical Ltd
Digital Therapeutics (DTx)
27th June 2023 @ 10:45AM EDT

Beyond Point Solutions: Will an Ecosystem Approach Unlock Digital Health’s Full Potential for Pharma?

Point solutions have been the norm for pharma to date. Brands create an app in isolation, often duplicating underlying infrastructure already created for other siloed products elsewhere in the company. Join your peers in this discussion led by Appnovation. Spaces are limited so apply now to secure your place.

Steve Peretz
Featuring
Steve Peretz
Healthcare Practice Lead, Appnovation
AI in Healthcare
21st June 2023 @ 10:45AM EDT

AI-driven Innovations for Clinical Decision Making

Artificial intelligence (AI) is beginning to seep into all aspects of healthcare - but its role as a tool for clinical decision making is still under scrutiny. Apply now to join your peers in this discussion. Spaces are limited so register now to secure your place.

Featuring
Digital Therapeutics (DTx)
20th June 2023 @ 10:45am EDT

Preparing Investment Rounds: Best Practices for DTx Startups

In the face of macroeconomic challenges and a tightening financial landscape, DTx startups are experiencing an intensified competition for investment. Join HealthXl in this peer led discussion to deep dive into this topic. Seats are limited so apply now to secure your place.

Tim Jurgens
Featuring
Tim Jurgens
Co-Founder & General Manager en SeedLink SL
Clinical Trials Innovation
15th June 2023 @ 10:45AM EDT

Innovation showcase: Remote Patient Monitoring (RPM) for Cardiovascular Diseases

In this innovation showcase, Pharma, Medtech and VC will meet 1-2-1 with potential Digital Health partners to discuss mutual challenges they face when building successful collaborations. Seats are limited to 3 Pharma/Medtech/VC and 3 digital health companies so we can pair you 1-2-1. Apply now to book your place!


Featuring
Digital Therapeutics (DTx)
13th June 2023 @ 10:45AM EDT

Existing and New Distribution Channels for DTx

Digital therapeutics (DTx) are yet to show success at scale with traditional salesforce distribution channels. Apply now to discuss this further with your peers working in this space.

Ed Melendez
Featuring
Ed Melendez
VP, Market Access, Vida Health
Telemedicine & Virtual Care Delivery
8th June 2023 @ 10:45AM EDT

Remote Patient Monitoring to Improve Surgical Workflows

Remote patient monitoring (RPM) technologies can benefit the entire surgical workflow, by allowing preoperative and postoperative monitoring that improves patient experience and reduces the overall cost of care. Apply now to secure your place as we deep dive into this topic.

Anupam Vats
Featuring
Anupam Vats
Co-Founder and Vice President of Growth & Partnerships, Pip Care
Telemedicine & Virtual Care Delivery
8th June 2023 @ 10:45AM EDT

Digital Health to Overcome the Siloed Care Pathways in Immunology

Digital health care pathways in immunology can become siloed due to the fragmentation of healthcare services and the lack of interoperability among healthcare systems and providers. Apply now to join this session and deep dive into this topic with your peers working in this space.

Thomas Hügle
Featuring
Thomas Hügle
Professor and Head of Rheumatology, University Hospital Lausanne (CHUV)
Digital Health in Oncology
7th June 2023 @ 10:45AM EDT

Integrating Oncology Digital Health into Clinical Practices

The benefits of digital technologies in oncology are undeniable; however, effectively demonstrating their value to end users is pivotal for the success of these products. Apply now to join your peers in this interactive discussion. Spaces are limited so apply now to secure your seat.

Madelyn Trupkin Herzfeld
Featuring
Madelyn Trupkin Herzfeld
Founder & Vice Chairman, Carevive
Digital Mental Health & Neurology
30th May 2023 @ 10:45AM EDT

Empowering Primary Care with Digital Health for Equitable Mental Wellbeing

The primary care model has become a key focus in mental health in the US due to a shortage of therapists and specialists. Join HealthXL in this meeting as we deep dive into this topic. Seats are limited so apply now to secure your place.

Daniel Emina
Featuring
Daniel Emina
Associate Medical Director, Amen Clinics, Inc.
Telemedicine & Virtual Care Delivery
23rd May 2023 @ 10:45am EDT

GPT for Life Sciences - What Does The Future Hold?

ChatGPT has revolutionised the way we work and play. From coding websites in minutes to crafting Shakespearean-style poems, this large language model (LLM) has infiltrated many aspects of our lives and made waves across all industries.
Junaid Bajwa
Featuring
Junaid Bajwa
Chief Medical Scientist at Microsoft
Digital Therapeutics (DTx)
18th May 2023 @ 10:45AM EDT

What does ‘a good DTx’ look like?

When it comes to digital therapeutics (DTx), there are many permutations, and what distinguishes a ‘good DTx’ can be difficult to define in a space that is constantly evolving. Apply now to join HealthXL in this session where we will deep dive into this topic. Apply now to secure your space, seats are limited.

Shrawan Patel
Featuring
Shrawan Patel
Founder & MD, Strategy Health
Telemedicine & Virtual Care Delivery
16th May 2023 @10:45AM EDT

Role Of Digital Health Across Brand Life Cycle In Pharma

Throughout each phase of a drug's life cycle, it is crucial to optimise both clinical and product value: from pre-launch and launch, to growth, maturity, and eventual decline. Apply now to join your peers to discuss this topic further.

Till Bauer
Featuring
Till Bauer
Global Oncology LCM Strategy Director at MSD
Digital Mental Health & Neurology
10th May 2023 @ 10:45AM EDT

The Power of Mental Health Improvement Tools: Showing Pharma Their Potential Across All Therapeutic Areas

While pharma is beginning to recognise the power of digital mental health tools, it is still challenging to get the true value recognition for these solutions. Join your peers to deep dive into this topic. Seats are limited so apply now to secure your place.

Carlos Rodarte
Featuring
Carlos Rodarte
Co-founder & CEO, Veriteos
Digital Therapeutics (DTx)
9th May 2023 @ 10:45AM EDT

How to Structure a Deal Between DTx and Pharma Companies?

Structuring a deal between pharmaceutical companies and digital therapeutics (DTx) companies can be complex, and the specifics will depend on various factors, including the therapeutic area to which the deal pertains, market size, and development stage of the DTx solution. Apply now to join your peers in this discussion.

Rick Bartels
Featuring
Rick Bartels
Managing Partner , DTxCC
Telemedicine & Virtual Care Delivery
9th May 2023 @ 10:15AM EDT

Pharma Brand Strategies for Driving HCP Engagement and Adoption with Sponsored DTx Solutions

In the aftermath of COVID-19, the patient journey has undergone considerable changes as digital tools and technologies have become increasingly integrated into the journey. Seats are limited. Apply now to join your peers in this discussion.

John Cairns
Featuring
John Cairns
Global Head of Digital, Oncology Franchise, Sanofi
Telemedicine & Virtual Care Delivery
4th May 2023 @ 10:15AM EDT

The Role of Medical Affairs in Advancing Digital Health

Medical affairs (MA) teams play a critical role in communicating with the wider medical fraternity and commercially supporting pharmacologics. Join us in this session where we will deep dive into this topic. Seats are limited so apply now to secure your place.

Alexander Klein
Featuring
Alexander Klein
Group Leader Digital Health, Roche
Digital Health in Oncology
2nd May 2023 @ 10:45AM EDT

Beyond the Provider: Alternative Paths to Adoption of Oncology Digital Health Solutions

Engaging healthcare providers is crucial to drive patient adoption of digital health solutions. Apply now to join HealthXL in this peer to peer discussion.

Andrew Norden
Featuring
Andrew Norden
Chief Medical Officer, OncoHealth
Telemedicine & Virtual Care Delivery
26th April 2023 @ 10AM GMT / 5PM AWST

Hybrid Care: How Could the Players in the Ecosystem Work Together to Make It Impactful?

Whilst the Covid-19 outbreak created strong incentives to go digital, it also demonstrated the value of in-person interactions. Apply now to join this session and dive deeper into this topic with your peers working in this space.

Till Bauer
Featuring
Till Bauer
Global Oncology LCM Strategy Director at MSD
Digital Health in Oncology
25th April 2023 @ 10:45AM EDT

Are Hospitals the Right Partner for Digital Health Companies in Oncology?

Digital health in oncology is still a very raw and undefined practice with companies still searching for a best approach to put these solutions into the patients' hands. Join this peer-to-peer conversation to deep dive into this discussion.

Eoin Tabb
Featuring
Eoin Tabb
A/ Chief II Pharmacist, Cancer Services, HSE
20th April 2023 @ 10:45AM EDT

Pharma 3.0: Doing Digital Health Better

Digital health’s interaction with pharma is evolving; it has to evolve. Join us in this roundtable to discuss the highlights from the report and how pharma can do digital health better in the next few years.

Jeremy Sohn
Featuring
Jeremy Sohn
Managing General Partner, P74 Ventures
Telemedicine & Virtual Care Delivery
18th April @ 10:45AM EDT

The Potential of OTC DTx Solutions

Curious about what is in store for the future of OTC DTx solutions? Join in the conversation with our expert panel to find out! Spaces are limited so apply now to secure your place.

Chris Wasden
Featuring
Chris Wasden
Chief Strategy Officer, Twill
Telemedicine & Virtual Care Delivery
11th April @ 10:45AM EDT

Embracing Digital Health for Hospital at Home Solutions

By reducing hospital admissions, and in-person care services, digital hospital at home solutions are emerging as cost-effective services for health systems. Join HealthXL in this discussion. Apply now to secure your place.

Aghogho Ekpruke
Featuring
Aghogho Ekpruke
Innovation Leader, MedTech Architect, Medtronic
Telemedicine & Virtual Care Delivery
6th April @ 10:45AM EDT

Panel Discussion: Patient Engagement Through a Digital Health Front Door

The digital front door is a powerful approach to improve patient engagement and care delivery, but it requires a patient-centric and holistic approach to be successful. Apply now to join HealthXL in this panel discussion with leaders working in this space.

Lee Shapiro
Featuring
Lee Shapiro
Managing Partner, 7wireVentures
Telemedicine & Virtual Care Delivery
5th April 2023 @ 10:45AM EDT

Data Monetisation for MedTech Companies

With the proliferation of digital health solutions developed and commercialised by MedTech firms, the volume of healthcare data they generate is expanding rapidly. Apply now to join your peers and discuss this topic further.

Lisa Suennen
Featuring
Lisa Suennen
Managing Partner, Venture Valkyrie, LLC
Digital Therapeutics (DTx)
30th March @ 10:45 AM EDT

Pharmacies in the US as a Distribution Model for DTx

The large pharmacy chains model in the US presents pharmacies as a promising distribution channel for Digital Therapeutics (DTx). Apply now to join this discussion with your peers working in this space.

Mark Thomas
Featuring
Mark Thomas
Healthcare Consultant, ProspHire
Digital Mental Health & Neurology
21st March @ 11:45AM EDT

Innovation Showcase: Digital Biomarkers in CNS and Cognition Assessment

In this innovation showcase, 3 Digital Biomarkers companies working on CNS and cognition assessment will meet 121 with 3 Pharma/Medtech/Investors to discuss mutual challenges when building successful collaborations. Seats are limited to 3  Pharma/Medtech/Investors and 3 Digital Biomarkers companies so we can pair you 1-2-1. Apply now to book your place!

Featuring
21st March 2023 @ 11:45AM EDT

Pharma 3.0: Doing Digital Health Better

Digital health’s interaction with pharma is evolving; it has to evolve. Join us in this roundtable to discuss how pharma can do digital health better in the next few years.

Jeremy Sohn
Featuring
Jeremy Sohn
Managing General Partner, P74 Ventures
Digital Therapeutics (DTx)
15th March @ 11:45AM EDT

Scalable Market Access Strategies Targeting Payers in the US

Despite DTx gaining traction in terms of investment, adoption still remains a challenge, and DTx companies struggle to secure reimbursement. Apply now to join your peers as we deep dive into this topic.

Michael Pace
Featuring
Michael Pace
CEO & Founder at PalmHealth.co
Digital Health in Oncology
14th March @ 11:45AM EDT

Patient Engagement Metrics in Digital Health for Oncology

Measuring patient engagement with digital health solutions is crucial to ensure the digital intervention is impactful and helps improve patient outcomes. Join this discussion to dive deeper into this topic with your peers working in this space. Seats are limited to apply now to secure your place.

Kate Wolin, ScD, FACSM, FSBM
Featuring
Kate Wolin, ScD, FACSM, FSBM
Founder, Circea
Digital Mental Health & Neurology
9th March 2023 @ 10:45 AM EDT

Extended-Reality (XR) Solutions in Mental Health and Substance Use Disorders

Extended Reality (XR) is a powerful technology that can be used anywhere, at any time. Join HealthXL in this meeting as we discuss this topic further. Seats are limited so apply now to secure your place.

Leonardo Angelone
Featuring
Leonardo Angelone
Deputy Director, Office of Translational Initiatives and Program Innovations, The National Institutes on Drug Abuse
Digital Health in Oncology
1st March @ 10:45AM EDT

Beyond Pharma: Finding the Best Commercial Partner for Digital Health in Oncology

Whilst digital health startups in oncology have tried to build prosperous partnerships with pharma, there are no outstanding results yet, and it has proven hard to make it work. Seats are limited for this event so apply now to deep dive into this topic with your peers.

Lavi Kwiatkowsky
Featuring
Lavi Kwiatkowsky
Founder & CEO, Canopy
Telemedicine & Virtual Care Delivery
23rd February @ 10:45AM EDT

Innovation Showcase: Digital Health Solutions in Oncology

In this innovation showcase, 3 Digital Health companies in Oncology will meet 121 with 3 Pharma/Medtech/Investors/Healthcare Providers, to discuss mutual challenges when building successful collaborations. Apply now to join this session as seats are limited.

Featuring
Digital Health in Oncology
21st February @ 10:45AM EDT

Standards for Robust Evidence from Digital Health in Oncology

Due to the lack of industry-wide evidence frameworks for digital health solutions in oncology, regulators' and payers' requirements are usually the same as drugs. Join HealthXL in this meeting to deep dive into this topic.

Simon Spahrkäs
Featuring
Simon Spahrkäs
Head of Research, Tired of Cancer
Digital Mental Health & Neurology
16th February @ 10:45AM EDT

Digital Biomarkers for Mental Health Evaluation and Management

Unlike other therapeutic areas, mental health evaluation and management can be a bit of an art, and at times relies on subjectivity in the outcomes analysis. Join this meeting to discuss this topic further with others working in this space. Places are limited so apply now to avoid disappointment.

George Eleftheriou
Featuring
George Eleftheriou
Co-founder & CEO, Feel Therapeutics
Digital Therapeutics (DTx)
15th February @ 10:45AM EDT

The Role of the Consumer Experience in DTx

As technology advances in all sectors (e.g. fintech, entertainment, etc), consumer behaviour changes and the expectations on user experience are higher than before. Apply now to secure your place in this meeting where you will dive deeper into this topic with your peers.

Lee Shapiro
Featuring
Lee Shapiro
Managing Partner, 7wireVentures
Telemedicine & Virtual Care Delivery
9th February @ 10:45AM EDT

Business Opportunities for Digital Health in Autoimmune Conditions: Upcoming Blockbuster Drugs

Millions of people worldwide suffer from autoimmune conditions such as rheumatoid arthritis (RA), psoriasis, lupus, Crohn's disease, multiple sclerosis, atopic dermatitis, to name a few. Join this meeting to deep dive into this topic in the Immunology Meeting Series. Seats are limited so apply now to secure your place.

Erik Janssen
Featuring
Erik Janssen
VP Global Digital Care Transformation Immunology, UCB
Digital Health Meeting
7th February @ 10:45AM EDT

Product Differentiation for Digital Health Solutions in the Cardiometabolic Disease Area

In the past few years, digital health solutions have proven to be helpful in preventing and managing cardiometabolic diseases remotely, leading to better  health outcomes and less hospitalizations, emergency visits, and in-office visits.

Jenn Roberts
Featuring
Jenn Roberts
Vice President Employer Health Strategy, Hello Heart
Digital Therapeutics (DTx)
23rd January @ 10:45AM EDT

Masterclass: How to Move from DTx Point Solutions to Platforms?

Why is now the right time to move from DTx point solutions to platforms? How to bring this to life? Join this meeting to discuss this topic further with your peers. Apply now to secure your seat.

Abhishek Shah
Featuring
Abhishek Shah
CEO, Wellthy Therapeutics
Digital Mental Health & Neurology
19th January @ 10:45AM EDT

Healthcare Provider Adoption of Digital Solutions in Mental Health

How can we help healthcare providers and health systems sift through the universe of digital solutions in mental health? How can digital health companies engage providers? Join this meeting to deep dive into this topic with your peers. Spaces are limited so apply now to secure your place.

Benjamin Alouf
Featuring
Benjamin Alouf
Member Scientific Advisory Board, Big Health
Telemedicine & Virtual Care Delivery
18th January @ 10:45AM EDT

Digital Health for Trigger Management in Autoimmune Conditions

It can be hard for HCPs to provide precise medical decisions in autoimmune conditions due to the patient variability and the trigger events not being fully understood. Join other senior leaders in this meeting to discuss this topic further.

Melinda Decker
Featuring
Melinda Decker
Fractional Chief Commercial Officer, Digital Health
Digital Therapeutics (DTx)
18th January @ 10:45AM EDT

Increase DTx Market Access and Adoption via Precision Patient Engagement

Market access and adoption are huge challenges in the DTx and Pharma/Life Sciences industry. Apply now to deep dive into this topic with your peers working in this space.

Bob Gold
Featuring
Bob Gold
Founder and Chief Behavioral Technologist, GoMo Health
Telemedicine & Virtual Care Delivery
17th January @ 10:45AM EDT

How Can Virtual Care Solutions Help Health Systems Bounce Back After Covid?

Health systems have been shocked in a way that has never been seen before with the COVID-19 pandemic. Join HealthXL in this meeting to discuss this topic with your peers working in this space.

Michael Freni
Featuring
Michael Freni
Vice President, Business Development, Innovation & Venture Partner, A.I. Digital Innovation Fund, Mass General Brigham
Digital Therapeutics (DTx)
11th January @ 10:45AM EDT

Revenue Generation in Pharma-DTx Partnerships

Many pharma companies have explored partnerships with DTx companies in the last few years, seeking for innovative technologies that add value to their products and services. Apply now to secure your place in this Digital Health meeting.

Ronny Hashmonay
Featuring
Ronny Hashmonay
Global Head of Business Transformation at Novartis
Digital Mental Health & Neurology
20th December @ 10:45AM EDT

The Intersection between DTx and Human Coaching in Mental Health

The connection between DTx and human coaching in mental health can weave together a more precise, personalized, and connected care experience. Apply now to join this meeting to discuss this topic further with your peers.

Eugene Borukhovich
Featuring
Eugene Borukhovich
COO & Co-Founder of YourCoach.Health
Digital Health in Oncology
15th December @ 10:45AM EDT

Innovation Showcase: Remote Patient Monitoring Programs in Oncology

In this innovation showcase, Pharma, Medtech, and VC will meet 1-2-1 with potential Digital Health partners to discuss mutual challenges they face when building successful collaborations. Spaces are limited so apply now to secure your place.

Mark Grossman
Featuring
Mark Grossman
VP Growth Strategies , GoMo Health
Digital Therapeutics (DTx)
14th December @ 10:45 AM EDT

Innovative Distribution Strategies for DTx

Currently, there is no one-size-fits-all strategy for DTx distribution. Join HealthXL in this meeting to discuss this topic further with your peers working in this space.

Francesca Wuttke
Featuring
Francesca Wuttke
CEO and Founder, nen Health